Abstract:The amyloid precursor protein (APP) is linked to the genetics and pathogenesis of Alzheimer's disease (AD). It is the parent protein of the β-amyloid (Aβ) peptide, the main constituent of the amyloid plaques found in an AD brain. The pathways from APP to Aβ are intensively studied, yet the normal functions of APP itself have generated less interest. We report here that glutamate stimulation of neuronal activity leads to a rapid increase in App gene expression. In mouse and human neurons, elevated APP protein changes the structure of the axon initial segment (AIS) where action potentials are initiated. The AIS is shortened in length and shifts away from the cell body. The GCaMP8f Ca 2+ reporter confirms the predicted decrease in neuronal activity. NMDA antagonists or knockdown of App block the glutamate effects. The actions of APP on the AIS are cell-autonomous; exogenous Aβ, either fibrillar or oligomeric, has no effect. In culture, APP Swe (a familial AD mutation) induces larger AIS changes than wild type APP. Ankyrin G and βIV-spectrin, scaffolding proteins of the AIS, both physically associate with APP, more so in AD brains. Finally, in humans with sporadic AD or in the R1.40 AD mouse model, both females and males, neurons have elevated levels of APP protein that invade the AIS. In vivo as in vitro , this increased APP is associated with a significant shortening of the AIS. The findings outline a new role for the APP and encourage a reconsideration of its relationship to AD. SIGNIFICANCE STATEMENT While the amyloid precursor protein (APP) has long been associated with Alzheimer's disease (AD), the normal functions of the full-length Type I membrane protein have been largely unexplored. We report here that the levels of APP protein increase with neuronal activity. In vivo and in vitro , modest amounts of excess APP alter the properties of the axon initial segment. The β-amyloid peptide derived from APP is without effect. Consistent with the observed changes in the axon initial segment which would be expected to decrease action potential firing, we show that APP expression depresses neuronal activity. In mouse AD models and human sporadic AD, APP physically associates with the scaffolding proteins of the axon initial segment, suggesting a relationship with AD dementia.

Human herpesvirus 6A U4 inhibits proteasomal degradation of amyloid precursor protein

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

An APP Mutation Family Exhibiting White Matter Hyperintensities and Cortical Calcification in East China

A CHCHD6–APP axis connects amyloid and mitochondrial pathology in Alzheimer's disease

Beta Amyloid-Induced Upregulation of Death Receptor 6 Accelerates the Toxic Effect of N-terminal Fragment of Amyloid Precursor Protein.

The Release and Transmission of Amyloid Precursor Protein Via Exosomes

Wwl70-induced ABHD6 inhibition attenuates memory deficits and pathological phenotypes in APPswe/PS1dE9 mice

The pathogenic APP N-terminal Val225Ala mutation alters tau protein liquid-liquid phase separation and exacerbates synaptic damage

Advances in the β-amyloid precursor protein of Alzheimer's disease

The Amyloid Precursor Protein Modulates the Position and Length of the Axon Initial Segment

Herpes Simplex Virus 1 Accelerates the Progression of Alzheimer’s Disease by Modulating Microglial Phagocytosis and Activating NLRP3 Pathway

ABHD6 inhibition alleviates memory deficits in an Alzheimer's disease mouse model

ABHD6 Inhibition Alleviates Memory Deficits in an Alzheimer’s Disease Mouse Model

Targeting m6A modification inhibits herpes virus 1 infection

Overexpression of wild-type human amyloid precursor protein alters GABAergic transmission

Herpes simplex virus 1 accelerates the progression of Alzheimer's disease by modulating microglial phagocytosis and activating NLRP3 pathway

Effects of U1 Small Nuclear Ribonucleoprotein Inhibition on the Expression of Genes Involved in Alzheimers Disease

PARP16-Mediated Stabilization of Amyloid Precursor Protein Mrna Exacerbates Alzheimer’s Disease Pathogenesis

Ubiquitin Hydrolase Uch-L1 Rescues Β-Amyloid-induced Decreases in Synaptic Function and Contextual Memory

The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer’s Disease

[The Interaction of the Intracellular Domain of Beta-Amyloid Precursor Protein with JKTBP2].